Search

everythinglearnresearchcommunity

for

Search:↓

Blocking the NOTCH pathway can prevent fibrosis in systemic sclerosis.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Keratin is crucial for keeping skin cells healthy and its changes can lead to diseases and affect cell behavior.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Permanent hair dye may cause total hair loss.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Topical vitamin D is effective in treating vitiligo with few side effects.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

A new microneedle patch helps repair spinal cord injuries by reducing scarring and promoting nerve growth.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.